Improving how we measure the effects of microbial keratitis on vision.
Improving Outcomes Assessment for Microbial Keratitis
This study is looking for better ways to measure how serious microbial keratitis is and how well treatments work, so that patients can get more effective care and improved treatment options for this eye condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11071976 on NIH RePORTER |
What this research studies
This research focuses on enhancing the assessment of outcomes for patients suffering from microbial keratitis, a serious eye condition that can lead to vision loss. The study aims to develop more accurate and objective methods for measuring the severity of this condition and the effectiveness of treatments. By addressing the limitations of current assessment techniques, the research seeks to improve the reliability of clinical trials and ensure that findings are applicable across different healthcare settings. Patients may benefit from better treatment options and improved care based on more precise evaluations of their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with microbial keratitis who are seeking treatment for this condition.
Not a fit: Patients with other types of corneal diseases or those who do not have microbial keratitis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and improved quality of life for patients with microbial keratitis.
How similar studies have performed: Previous research has struggled with similar challenges in measuring outcomes for microbial keratitis, indicating that this approach is both necessary and innovative.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Shekhawat, Nakul — Johns Hopkins University
- Study coordinator: Shekhawat, Nakul
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.